Company code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) company abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) bond Code: 113585 bond abbreviation: Shouxian convertible bond Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
ZhejiangShouxianguPharmaceuticalCo., Ltd.
(No. 10, Shangcheng Road, Hushan street, Wuyi County, Zhejiang Province)
Annual report for 2021
April 1, 2002
Important tips
1、 The board of directors, board of supervisors, directors, supervisors and senior managers of the company guarantee the authenticity, accuracy and integrity of the contents of the annual report, and there are no false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2、 All directors of the company attended the board meeting. 3、 Lixin Certified Public Accountants (special general partnership) issued a standard unqualified audit report for the company. 4、 Person in charge of accounting and financial reporting: Zhu Mingyan, the person in charge of accounting and financial reporting of the company. 5、 The profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period adopted by the resolution of the board of directors
The company plans to distribute a cash dividend of 4.05 yuan (including tax) to all shareholders for every 10 shares based on the total share capital on the date of profit distribution equity registration in 2021 minus the shares in the special account for repurchase, and increase 3 shares for every 10 shares to all shareholders in the form of capital reserve converted into share capital. If the total share capital of the company changes before the equity registration date of equity distribution, it is proposed to maintain the distribution (conversion) ratio per share unchanged and adjust the total distribution (conversion) accordingly. 6、 Risk statement of forward-looking statements √ applicable □ not applicable
The forward-looking description involved in this report does not constitute the company’s substantive commitment to investors. Please pay attention to investment risks. 7、 Whether there is any non operational occupation of funds by the controlling shareholders and their related parties? VIII. Whether there is any external guarantee in violation of the specified decision-making procedures? IX. whether more than half of the directors cannot guarantee the authenticity, accuracy and integrity of the annual report disclosed by the company? X. major risk tips
During the reporting period, there were no major risks that had a substantial impact on the company’s production and operation. The company has described the possible risks in detail in this report. Please refer to the relevant contents of “possible risks” in “section III Management Discussion and analysis”. 11、 Others □ applicable √ not applicable
catalogue
Section 1 interpretation three
Section II Company Profile and main financial indicators Section III Management Discussion and Analysis Section 4 corporate governance 53 Section V environmental and social responsibility 71 section VI important matters Section VII share changes and shareholders Section VIII preferred shares 99 section IX relevant information of bonds Section x financial report one hundred and three
Annual report signed by the chairman of the company
Financial report containing the list of documents for annual reference signed and sealed by the company’s legal representative, the person in charge of accounting and the person in charge of accounting
Annual audit report with the seal of accounting firm and the seal of Certified Public Accountant
The originals of all documents and announcements publicly disclosed on the media designated by the CSRC during the reporting period
Section I interpretation
1、 In this report, unless the context otherwise requires, the following words have the following meanings:
Interpretation of common words
The company, the company and Shouxian refer to Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
valley
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical refers to Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) decoction pieces refer to Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine decoction pieces Co., Ltd., which is a wholly-owned subsidiary of the company
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmacy refers to Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmacy chain Co., Ltd., which is a wholly-owned subsidiary of the company
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) network refers to Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Network Technology Co., Ltd., which is a wholly-owned subsidiary of the company
Kangshou pharmaceutical refers to Jinhua Kangshou Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Research Institute refers to Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Botanical Medicine Research Institute Co., Ltd., which is a wholly-owned subsidiary of the company
Hangzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Hangzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Management Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical
Beijing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Beijing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical
Suzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Suzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmacy Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical
Shanghai Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Shanghai Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Biotechnology Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical
Nanjing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Nanjing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical
Wenhe Jinxian refers to Wenzhou Wenhe Jinxian Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kangshou pharmaceutical
Fanghuichuntang outpatient department refers to Hangzhou fanghuichuntang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine outpatient department Co., Ltd., which is a joint-stock company of the company
Fanghuichuntang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) hall refers to Hangzhou fanghuichuntang Pharmacy Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) hall Co., Ltd., which is a joint-stock company of the company
Qianjiahui refers to Zhejiang qianjiahui Biotechnology Co., Ltd., which is a joint-stock company of the company
Haojing network refers to Hangzhou Haojing Network Technology Co., Ltd., which is a joint-stock company of the company
Zheshang Jiantou refers to Zhejiang Zheshang Jiantou Asset Management Co., Ltd., which is a joint-stock company of the company
Yecun investment refers to Kunshan Yecun Investment Center (limited partnership), which is a joint-stock partnership of the company
Qingyu Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) refers to Jinhua Qingyu Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) National Pharmaceutical Co., Ltd., which is a joint-stock company of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical industry
Time honored information technology refers to Zhejiang time honored new information technology Co., Ltd., a joint-stock company of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical industry
Wuyi commercial bank refers to Zhejiang Wuyi Rural Commercial Bank Co., Ltd., a joint-stock company of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical industry
Wuyi Bank of China fudeng bank refers to Zhejiang Wuyi Bank of China fudeng Village Bank Co., Ltd., which is a joint-stock company of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) pharmaceutical industry
Controlling shareholder, Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) investment refers to Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Investment Management Co., Ltd., which is the controlling shareholder of the company
Endowment
Actual controller refers to Li Mingyan family (Li Mingyan, Zhu huizhao, Li Zhenhao, Li Zhenyu)
Fungi Research Institute refers to Wuyi County Fungi Research Institute, which is the control enterprise of Li Mingyan, the actual controller
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) tourism refers to Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Tourism Co., Ltd., which is a wholly-owned subsidiary invested by Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) investment
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) health technology refers to Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd., which is a controlled enterprise invested by Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) investment
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) travel agency refers to Wuyi Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Travel Agency Service Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) tourism
Hexiujing power refers to Hejing County kekewusu Hydropower Development Co., Ltd., which is a joint-stock company of Li Mingyan, the actual controller
Medicinal materials produced in areas with specific natural conditions and ecological environment, including plant traditional Chinese medicine, refer to medicinal materials, animal medicinal materials, mineral medicinal materials, etc., which are the raw materials of traditional Chinese medicine pieces before processing
Decoction pieces and decoction pieces of traditional Chinese medicine refer to the drugs that can be directly used in the clinical practice of traditional Chinese medicine after standardized processing of traditional Chinese medicine and reducing toxicity and increasing efficiency according to the theory of traditional Chinese medicine
Processing and processing technology refers to a pharmaceutical technology adopted according to the theory of traditional Chinese medicine, the needs of treatment and medication, the nature of drugs, and the different requirements of dispensing and preparation
Chinese patent medicine refers to the traditional Chinese medicine products of different dosage forms made from prepared pieces of traditional Chinese medicine as the main raw material, including pills, powders, creams, pills, capsules, injections, etc
Health food refers to food that claims to have specific health care functions or for the purpose of supplementing vitamins and minerals.
That is, it is suitable for specific people to eat, has the function of regulating the body, is not for the purpose of treating diseases, and does not produce any acute, subacute or chronic harm to the human body
Ganoderma lucidum rod refers to the raw material for producing Ganoderma lucidum fruiting body, which is made by putting pieces of wood into plastic bags, often pressing and sterilizing, then connecting with Ganoderma lucidum strains and fermenting
Ganoderma lucidum refers to the dried fruiting body of Ganoderma lucidum or Ganoderma lucidum
Ganoderma lucidum spore powder refers to the dried and mature spores of Ganoderma lucidum, a fungus of porous fungi family
The dried stem of Dendrobium candidum, an orchid plant, is cut into segments and dried or dried at low temperature. It is commonly known as Dendrobium candidum and Dendrobium candidum, referring to “Dendrobium candidum”; Or heat it, twist it into a spiral or spring shape, and dry it. It is commonly known as “iron Maple bucket”
Crocus refers to the dried stigma of crocus in Iridaceae
Good manufacturing practice is the basic criterion for drug production and quality management. GMP is applicable to the whole process of drug preparation production and the key links affecting the quality of finished products in API production
Chinese Pharmacopoeia and pharmacopoeia refer to the Pharmacopoeia of the people’s Republic of China
Zhejiang gun regulation refers to the “Zhejiang provincial standard for the processing of traditional Chinese medicine”
Direct stores refer to independent stores opened by the company and its subsidiaries. The company and its subsidiaries are responsible for the management of stores and bear corresponding expenses
Distributor refers to the legal entity or natural person that signs an annual distribution contract with the company to sell the company’s products through its own retail terminals or to its subordinate retailers
Section II Company Profile and main financial indicators
1、 Company information
Chinese name of the company Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
Chinese abbreviation of the company Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
The foreign language name of the company is zhejiangshouxiangu Pharmaceutical Co, Ltd.
The abbreviation of the company’s foreign name is shouxiangu
Legal representative of the company: Li Mingyan
2、 Contact person and contact information
Secretary of the board securities Officer
Name: Liu Guofang, Liu Jia
Contact address: No. 12, Huanglong Third Road, Wuyi County, Zhejiang Province No. 12, Huanglong Third Road, Wuyi County, Zhejiang Province
Tel: 057987622285
Fax: 057987621769
